Prevalence, self-care behaviors, and self-care activities for peripheral neuropathy symptoms of HIV/AIDS

Nursing and Health Sciences

Volumn 12, Issue 1, 2010, Pages 119-126

  Nicholas, Patrice K ^a   Voss, Joachim ^b   Wantland, Dean ^c   Lindgren, Teri ^c   Huang, Emily ^c   Holzemer, William L ^c   Cuca, Yvette ^c   Moezzi, Shahnaz ^d   Portillo, Carmen ^c   Willard, Suzanne ^e   Arudo, John ^f   Kirksey, Kenn ^g   Corless, Inge B ^a   Rosa, María E ^h   Robinson, Linda ⁱ   Hamilton, Mary J ^j   Sefcik, Elizabeth ^j   Human, Sarie ^k   Rivero Mendez, Marta ^h   Maryland, Mary ^l   Nokes, Kathleen M ^m   Eller, Lucille ⁿ   Kemppainen, Jeanne ^o   Dawson Rose, Carol ^c   Brion, John M ^p   Bunch, Elli H ^q   Shannon, Maureen ^r   Nicholas, Thomas P ^s   Viamonte Ros, Ana ^t   Bain, Catherine A ^c   more..

^a MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e DREXEL UNIVERSITY   (United States)

^f AGA KHAN UNIVERSITY   (Pakistan)

^g Department of Nursing Research   (United States)

^h UNIVERSITY OF PUERTO RICO   (Puerto Rico)

ⁱ SAN DIEGO STATE UNIVERSITY   (United States)

^j TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

^k UNIVERSITY OF SOUTH AFRICA   (South Africa)

^l One of the City Colleges of Chicago   (United States)

^m RUTGERS UNIVERSITY   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

^o DUKE UNIVERSITY   (United States)

^p CITY UNIVERSITY OF NEW YORK   (United States)

^q UNIVERSITY OF OSLO   (Norway)

^r University of Hawaii at Manoa School of Nursing and Dental Hygiene   (United States)

^s BRIGHAM AND WOMEN S HOSPITAL   (United States)

^t FLORIDA DEPARTMENT OF HEALTH   (United States)

more..

Author keywords

HIV AIDS; Peripheral neuropathy; Self care; Symptom management

Indexed keywords

ANALGESIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ALTERNATIVE MEDICINE; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PREVALENCE; RISK ASSESSMENT; SELF CARE; SEX RATIO; STANDARD; STATISTICS; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ANALGESICS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; COMPLEMENTARY THERAPIES; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT COMPLIANCE; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; RISK ASSESSMENT; RISK-TAKING; SELF CARE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 77950125483     PISSN: 14410745     EISSN: 14422018     Source Type: Journal    
DOI: 10.1111/j.1442-2018.2009.00505.x     Document Type: Article

References (28)

1. Arenas-Pinto A, Bhaskaran K, Dunn D, Weller IV. The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antivir. Ther. 2008, 13:289-295.
2. Chiechio S, Copani A, Gereau RW, Nicoletti F. Acetyl-L-carnitine in neuropathic pain: Experimental data. CNS Drugs 2007, 21:31-38. Suppl.
3. Dorsey SG, Morton PG. HIV peripheral neuropathy: Pathophysiology and clinical implications. AACN Clin. Issues 2006, 17:30-36.
4. Ellis RJ, Marquie-Beck J, Delaney P. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann. Neurol. 2008, 64:566-572.
5. Ferrari S, Vento S, Monaco S. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin. Proc. 2006, 81:213-219.
6. Fogarty A, Rawstorne P, Prestage G, Crawford J, Grierson J, Kippax S. Marijuana as therapy for people living with HIV/AIDS: Social and health aspects. AIDS Care 2007, 19:295-301.
7. Gerschenson M, Brinkman K. Mitochondrial dysfunction in AIDS and its treatment. Mitochondrion 2004, 4:763-777.
8. Gonzalez-Duarte A, Cikurel K, Simpson DM. Managing HIV peripheral neuropathy. Curr. HIV/AIDS Rep. 2007, 4:114-118.
9. Harrison MJG, McArthur JC. AIDS and Neurology 1995, Edinburgh, Churchill Livingstone
10. Holzemer WL. HIV and AIDS: The symptom experience. Am. J. Nurse 2002, 102:48-52.
11. Holzemer WL, Hudson A, Kirksey KM, Hamilton MJ, Bakken S. The revised sign and symptom checklist for HIV (SSC-HIVrev). J. Assoc. Nurses AIDS Care 2001, 12:60-70.
12. Lichtenstein KA, Armon C, Baron A. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin. Infect. Dis. 2004, 40:84-94.
13. Nicholas PK, Kemppainen J, Holzemer WL. Self-care management for peripheral neuropathy in HIV/AIDS. AIDS Care 2002, 14:763-771.
14. Nicholas PK, Kemppainen JK, Canaval GE. Symptom management and self-care for peripheral neuropathy in HIV/AIDS. AIDS Care 2007a, 19:179-189.
15. Nicholas PK, Slate A, Mauceri L, Corless IB, Raymond N, Viamonte Ros A. Distal symmetrical polyneuropathy in the context of HIV/AIDS. J. Assoc. Nurses AIDS Care 2007c, 18:32-40.
16. Nicholas PK, Voss J, Corless IB. Unhealthy behaviors for self-management of HIV-related peripheral neuropathy. AIDS Care 2007b, 19:1266-1273.
17. Pardo CA, McArthur JC, Griffin JW. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J. Peripher. Nerv. Syst. 2001, 6:21-27.
18. Parry O, Mielke J, Latif AS, Ray S, Levy LF, Siziya S. Peripheral neuropathy in individuals with HIV infection in Zimbabwe. Acta Neurol. Scand. 1997, 96:218-222.
19. Price RW. Neurological complications of HIV infection. Lancet 1996, 348:445-452.
20. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst. Rev. 2005, CD005454
21. Schifitto G, McDermott MP, McArthur JC. Dana Consortium on the therapy of HIV dementia and related cognitive disorders. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002, 58:1764-1768.
22. Schifitto G, McDermott MP, McArthur JC. The NEAD Consortium. Markers of immune activation and viral load in HIV-associated sensory neuropathy. Neurology 2005, 64:842-848.
23. Simpson DM, Cikurel K. Neurologic and psychiatric adverse effects of antiretroviral agents. Neurologic Aspects of HIV/AIDS: New Insights and Management Advances 2006, http://www.clinicaloptions.com/neuroaids, In, Cited 15 Apr 2009.] Available from URL:
24. Swanson B, Zeller JM, Paice JA. HIV-associated distal symmetrical polyneuropathy: clinical features and nursing management. J. Assoc. Nurses AIDS Care 1998, 9:77-80.
25. Verma S, Estanislao L, Mintz L, Simpson D. Controlling neuropathic pain in HIV. Curr. HIV/AIDS Rep. 2004, 1:136-141.
26. Verma S, Estanislao L, Simpson D. Controlling neuropathic pain in HIV: epidemiology, pathophysiology and treatment. CNS Drugs 2005, 19:325-334.
27. Wulff EA, Wang AK, Simpson D. HIV-associated peripheral neuropathy: epidemiology, pathophysiology, and treatment. Drugs 2000, 59:1251-1260.
28. Youle M, Osio M. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl l-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med. 2007, 8:241-250. ALCAR Study Group